Involvement of 5-HT 3 receptors in the action of vortioxetine in rat brain: Focus on glutamatergic and GABAergic neurotransmission
Open Access
- 1 September 2016
- journal article
- research article
- Published by Elsevier in Neuropharmacology
- Vol. 108, 73-81
Abstract
No abstract availableKeywords
Funding Information
- Lundbeck A/S (SAF 2012-35183, 2015-68346-P)
- Spanish Ministry of Economy and Competitiveness
- European Regional Development Fund (ERDF) (PI12/00156)
- Instituto de Salud Carlos III
- European Regional Development Fund (ERDF)
- Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM)
- Generalitat de Catalunya Grup de Recerca Consolidat (2014SGR798)
This publication has 50 references indexed in Scilit:
- New insights into the classification and nomenclature of cortical GABAergic interneuronsNature Reviews Neuroscience, 2013
- 5-HT3AReceptor-Bearing White Matter Interstitial GABAergic Interneurons Are Functionally Integrated into Cortical and Subcortical NetworksJournal of Neuroscience, 2011
- A double-blind, randomized, placebo-controlled, active reference study of Lu AA21004 in patients with major depressive disorderInternational Journal of Neuropsychopharmacology, 2011
- The pyramidal neurons in the medial prefrontal cortex show decreased response to 5-hydroxytryptamine-3 receptor stimulation in a rodent model of Parkinson's diseaseBrain Research, 2011
- The Largest Group of Superficial Neocortical GABAergic Interneurons Expresses Ionotropic Serotonin ReceptorsThe Journal of Neuroscience, 2010
- Regulation of cortical microcircuits by unitary GABA-mediated volume transmissionNature, 2009
- Fast Synaptic Subcortical Control of Hippocampal CircuitsScience, 2009
- Antipsychotic drugs reverse the disruption in prefrontal cortex function produced by NMDA receptor blockade with phencyclidineProceedings of the National Academy of Sciences, 2007
- In Vivo Excitation of GABA Interneurons in the Medial Prefrontal Cortex through 5-HT3 ReceptorsCerebral Cortex, 2004
- Acceleration of the effect of selected antidepressant drugs in major depression by 5-HT1A antagonistsTrends in Neurosciences, 1996